FR2492260B1 - - Google Patents

Info

Publication number
FR2492260B1
FR2492260B1 FR8119522A FR8119522A FR2492260B1 FR 2492260 B1 FR2492260 B1 FR 2492260B1 FR 8119522 A FR8119522 A FR 8119522A FR 8119522 A FR8119522 A FR 8119522A FR 2492260 B1 FR2492260 B1 FR 2492260B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8119522A
Other languages
French (fr)
Other versions
FR2492260A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of FR2492260A1 publication Critical patent/FR2492260A1/en
Application granted granted Critical
Publication of FR2492260B1 publication Critical patent/FR2492260B1/fr
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8119522A 1980-10-17 1981-10-16 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COAGULATION FACTOR VIII Granted FR2492260A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
FR2492260A1 FR2492260A1 (en) 1982-04-23
FR2492260B1 true FR2492260B1 (en) 1984-07-27

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8119522A Granted FR2492260A1 (en) 1980-10-17 1981-10-16 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COAGULATION FACTOR VIII

Country Status (5)

Country Link
JP (1) JPS5770814A (en)
DE (1) DE3141223A1 (en)
ES (1) ES506320A0 (en)
FR (1) FR2492260A1 (en)
GB (1) GB2085729B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (en) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma THERAPEUTIC PROCEDURE FOR THE USE OF EMBORNED LIPOSOMES FRUCTOSE 1.6 DIPHOSPHATE AND PROCEDURE FOR THE PREPARATION OF THE SAME
JPS6150912A (en) * 1984-08-16 1986-03-13 Shionogi & Co Ltd Production of liposome preparation
FR2581543B1 (en) * 1985-05-09 1989-07-07 Tressens Dominique PHARMACOTECHNIE ALLOWING THE PRODUCTION OF AN ORAL ACTIVE INSULIN PREPARATION
DE3625090A1 (en) * 1986-07-24 1988-01-28 Behringwerke Ag AGENT FOR THE THERAPY FACTOR VIII-RESISTANT HAEMOPHILY A AND METHOD FOR THE PRODUCTION THEREOF
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (en) * 1991-05-11 1992-11-12 Knoll Ag NEW ACTIVE COMPOUND
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (en) * 1993-06-18 1995-08-18 Franche Comte Universite Basifying product in gastro-resistant form.
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416180C2 (en) * 1994-05-06 1997-08-14 Immuno Ag Stable preparation for the treatment of blood coagulation disorders and method for producing this preparation
DE4416166C2 (en) * 1994-05-06 1997-11-20 Immuno Ag Stable preparation for the treatment of blood clotting disorders
CH689139A5 (en) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Process for the preparation of a liposomal, in water dispersable, orally administrable, solid, dry therapeutic formulation.
AU9221698A (en) * 1997-09-04 1999-03-22 Biozone Laboratories, Inc. Oral liposomal delivery system
DE60035260T2 (en) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington NEW ALBUMIN FREE FACTOR VIII FORMULATIONS
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
DE102009001334B4 (en) 2009-03-04 2017-02-23 Stefan Brosig Simple enteric encapsulation, e.g. of ginger and other delicate substances
CN109316599A (en) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 A kind of Aprotinin or its mutant, derivative, analog or its application for forming segment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (en) * 1971-10-12 1973-05-30 Inchema S A PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS
NL7900459A (en) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D PHARMACEUTICAL PREPARATION AND METHOD OF PREPARATION THEREOF.

Also Published As

Publication number Publication date
GB2085729B (en) 1984-04-18
GB2085729A (en) 1982-05-06
JPS5770814A (en) 1982-05-01
ES8306323A1 (en) 1983-05-16
ES506320A0 (en) 1983-05-16
DE3141223A1 (en) 1982-06-24
JPH03366B2 (en) 1991-01-07
FR2492260A1 (en) 1982-04-23

Similar Documents

Publication Publication Date Title
FR2475646B1 (en)
FR2474982B1 (en)
FR2476022B1 (en)
FR2476911B1 (en)
JPS5712388U (en)
FR2474193B1 (en)
BR8108722A (en)
CH655452B (en)
DE3107826C2 (en)
FR2475561B1 (en)
CH629354GA3 (en)
FR2476537B1 (en)
DE3050632A1 (en)
FR2476066B1 (en)
FR2475734B1 (en)
FR2476104B1 (en)
DE3117743C2 (en)
FR2474865B1 (en)
DE3034115C2 (en)
FR2475700B1 (en)
FR2473456B3 (en)
FR2473170B1 (en)
FR2473455B1 (en)
FR2475791B1 (en)
DE3040877C2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse